Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple undefined cellular and extracellular matrix components" refers to a non-specific target classification used in pharmacological databases for therapeutic agents that interact with a wide variety of tissue elements rather than a single molecular entity (ChEMBL, 2024). These elements include various cell types and the extracellular matrix (ECM), a complex scaffold of proteins and carbohydrates that provides structural support and biochemical signaling to tissues (Nature Reviews Molecular Cell Biology, 2022). In drug discovery, this designation is often applied to substances like talc, surgical glues, or sclerosants that exert their effects through physical or chemical irritation across multiple biological structures (StatPearls, 2023). Because these agents do not bind to a specific receptor or enzyme, their mechanism of action is considered multi-faceted and lacks molecular specificity. This target category is crucial for understanding the pharmacology of medical devices and non-targeted therapies used in wound healing and pleurodesis. The biological role of the components involved includes maintaining tissue integrity, facilitating cell adhesion, and regulating the local inflammatory environment. In disease states, these components may be manipulated to promote tissue fusion or to seal leaks, such as in the treatment of persistent pleural effusions. However, the lack of specificity can lead to safety concerns such as chronic inflammation or unintended fibrosis at the site of application.
Non-specific physical or chemical interaction with various cellular and extracellular structures to induce a physiological response such as adhesion, inflammation, or structural reinforcement (ChEMBL, 2024).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple undefined cellular and extracellular matrix components.